You are currently viewing Noble Trial

Noble Trial

Noble Trial

European Bifurcation Club 2010, EBC 2010 – Budapest, Hungary

LM upcoming studies: place of techniques?

Noble Trial

Author: Leif Thuesen, MD, Aarhus University Hospital, Skejby, Denmark



In a clinical, randomized, 5-year follow-up study to compare essential clinical outcome parameters in patients with unprotected left main (LMCA) disease, treated with coronary artery bypass grafting versus percutaneous coronary intervention using drug eluting stents.


DES-PCI of unprotected LMCA disease is non-inferior to CABG concerning the 2-year rate of death, myocardial infarction, stroke or new revascularization.


Download here

Leave a Reply